However, in IBD patients, in attempt to maintain normal homeostasis and to hinder as much as possible CD4+ T effector cell induced inflammation, they remain unable to counterbalance the process of mucosal inflammation [6, 7]. The gene discussed is CD4; the disease is inflammatory bowel disease.